Apyx Medical Corp logo

Apyx Medical Corp

$ 7.06 -0.17 (-2.35%) 08:09 PM EST
P/E:
At Loss
P/B:
5.33
Market Cap:
$ 244.09M
Enterprise V:
$ 230.70M
Volume:
132.37K
Avg Vol (2M):
294.13K
Also Trade In:
Volume:
132.37K
Market Cap $:
244.09M
PE Ratio:
At Loss
Avg Vol (2-Month):
294.13K
Enterprise Value $:
230.70M
PB Ratio:
5.33
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Apyx Medical Corp
NAICS : 339112 SIC : 3841
5115 Ulmerton Road, Clearwater, FL, USA, 33760
Compare
Compare
CLPT ANIK XAIR AXGN EDAP OWLT RXST APEN CODX SPNE ABT MDT SYK EW BSX SZSE:300760 DXCM ZBH STE ALGN
Traded in other countries / regions
BOV.Germany APYX.USA
Description
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 25.02
Equity-to-Asset 0.77
Debt-to-Equity 0.02
Debt-to-EBITDA -0.05
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.4
Distress
Grey
Safe
Beneish M-Score -2.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.86
9-Day RSI 28.03
14-Day RSI 37.03
6-1 Month Momentum % -24.24
12-1 Month Momentum % -27.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.45
Quick Ratio 3.6
Cash Ratio 1.77
Days Inventory 157.73
Days Sales Outstanding 79.71
Days Payable 61.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.7

Financials (Next Earnings Date:2022-11-11 Est.)

APYX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:APYX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 51.44
EPS (TTM) ($) -0.51
Beta 1.58
Volatility % 113.67
14-Day RSI 37.03
14-Day ATR ($) 0.786701
20-Day SMA ($) 9.33725
12-1 Month Momentum % -27.88
52-Week Range ($) 3.01 - 17.5
Shares Outstanding (Mil) 34.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Apyx Medical Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More